StopWatch Media’s ‘Clinical Trials’ medical app puts government database at fingertips of physicians and health care practitioners. – Before today, searching for one of more than 71,500 clinical trials in the National Library of Medicine and National Institutes of Health database required a chair, computer, internet connection, and a session on the government’s clinical trials website.
Questions of ethics and quality cloud globalization of clinical trials – Top-tier U.S.-based pharmaceutical companies are moving their clinical trials overseas at warp speed, raising questions about ethics, quality control, and even the scientific value of their findings for people back in the U.S.
Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy. Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury. – Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
Living Cell Technologies receives New Zealand’s Health Minister?s approval to start leading edge live cell therapy clinical trial in New Zealand for Diabetes patients. – Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) announced that New Zealand Health Minister, the Honorable David Cunliffe, has approved an application from the company to conduct in New Zealand a Phase I/IIa clinical trial of DiabeCell?, LCT’s lead product candidate for the treatment of insulin dependent (Type 1) diabetes.
Over half of all supporting trials determining efficacy for FDA-approved drugs with statistically significant results and larger sample sizes remained unpublished 5 years after approval. – Over half of all supporting trials for FDA-approved drugs remained unpublished 5 years after approval, says new research published in this week’s PLoS Medicine. The most important trials determining efficacy, and those with statistically significant results and larger sample sizes, are more likely to be published.
Special issue of JACC features intriguing link between statins and Atrial Fibrillation (AF) prevention, tools to ensure the highest-quality AF care, and more. – When we’re young, a racing heart often means love is in the air. If you’re a “baby boomer,” it might mean you’ve just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart’s rhythm that grows more common as we age and markedly increases the risk for stroke.
Researchers are hoping to develop the first treatment for broken bones using a patient’s own stem cells. – Scientists are developing a revolutionary way to mend damaged bones and cartilage using a patient’s own stem cells.
Evidence-based medicine is valuable to the extent that the evidence base is complete and unbiased. Selective publication of clinical trials ? and the outcomes within those trials ? can lead to unrealistic estimates of drug effectiveness and alter the apparent risk?benefit ratio. – Selective publication in reporting results of antidepressant trials exaggerates the effectiveness of the drugs, and may have adverse consequences for researchers, study participants, health care professionals, and patients, revealed in a new study.
In the labyrinth of the human body, a multitude of microscopic life forms thrive, shaping our health, emotions, and overall wellbeing. Among these microorganisms, there
Innovative research from the University of Eastern Finland suggests that consuming fatty fish and camelina sativa oil can decrease the lipophilic index in individuals with
